CLINICAL TRIALS PROFILE FOR VALTOCO
✉ Email this page to a colleague
All Clinical Trials for VALTOCO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05076838 ↗ | Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy | Recruiting | Neurelis, Inc. | Phase 1/Phase 2 | 2021-11-01 | This is a Phase 1/2a, open-label, single-dose, PK study of VALTOCO with open-label safety period in pediatric epilepsy subjects age 2 to 5 years. |
| NCT05273398 ↗ | Effects of Diazepam on RNS Detections | Not yet recruiting | University of Cincinnati | Phase 4 | 2022-03-01 | To assess the magnitude and duration of reduction in RNS recorded Detections and Long Episodes following intranasal administration of Valtoco®. All participants will have been implanted and treated with an RNS system for clinical purposes and regularly upload Detection and Long Episode data on a regular basis as part of regular clinical treatment. Participants will come to the clinic and be administered a single dose of Valtoco® via nasal spray. RNS recorded Detections and Long Episodes before and after Valtoco® administration will be compared. This is a pilot study, so all outcomes are exploratory. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VALTOCO
Condition Name
Clinical Trial Locations for VALTOCO
Trials by Country
Clinical Trial Progress for VALTOCO
Clinical Trial Phase
Clinical Trial Sponsors for VALTOCO
Sponsor Name
